Literature DB >> 30897496

Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.

Radhika Rawat1, Daniel T Starczynowski2, Panagiotis Ntziachristos3.   

Abstract

Ubiquitination is a versatile and tightly regulated post-translational protein modification with many distinct outcomes affecting protein stability, localization, interactions, and activity. Ubiquitin chain linkages anchored on substrates can be further modified by additional post-translational modifications, including phosphorylation and SUMOylation. Deubiquitinases (DUBs) reverse these ubiquitin marks with matched levels of precision. Over hundred known DUBs regulate a wide variety of cellular events. In this review, we focus on ubiquitin-specific protease 7 (USP7, also known as herpesvirus-associated ubiquitin-specific protease, or HAUSP) as one of the best studied, disease-associated DUBs. By highlighting the functions of USP7, particularly in the nucleus, and the emergence of the newest generation of USP7 inhibitors, we illustrate the importance of individual DUBs in the nucleus, and the therapeutic prospects of DUB targeting in human disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30897496      PMCID: PMC6986459          DOI: 10.1016/j.ceb.2019.02.008

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  105 in total

1.  Tumour suppression: disruption of HAUSP gene stabilizes p53.

Authors:  Jordan M Cummins; Carlo Rago; Manu Kohli; Kenneth W Kinzler; Christoph Lengauer; Bert Vogelstein
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 2.  Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218).

Authors:  Benedikt M Kessler
Journal:  Expert Opin Ther Pat       Date:  2014-01-24       Impact factor: 6.674

Review 3.  The increasing complexity of the ubiquitin code.

Authors:  Richard Yau; Michael Rape
Journal:  Nat Cell Biol       Date:  2016-05-27       Impact factor: 28.824

4.  Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.

Authors:  Gerald Gavory; Colin R O'Dowd; Matthew D Helm; Jakub Flasz; Elias Arkoudis; Anthony Dossang; Caroline Hughes; Eamon Cassidy; Keeva McClelland; Ewa Odrzywol; Natalie Page; Oliver Barker; Hugues Miel; Timothy Harrison
Journal:  Nat Chem Biol       Date:  2017-12-04       Impact factor: 15.040

5.  Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities.

Authors:  Frank Stegmeier; Michael Rape; Viji M Draviam; Grzegorz Nalepa; Mathew E Sowa; Xiaolu L Ang; E Robert McDonald; Mamie Z Li; Gregory J Hannon; Peter K Sorger; Marc W Kirschner; J Wade Harper; Stephen J Elledge
Journal:  Nature       Date:  2007-04-19       Impact factor: 49.962

6.  Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.

Authors:  Reinaldo Franqui-Machin; Mu Hao; Hua Bai; Zhimin Gu; Xin Zhan; Hasem Habelhah; Yogesh Jethava; Lugui Qiu; Ivana Frech; Guido Tricot; Fenghuang Zhan
Journal:  J Clin Invest       Date:  2018-06-04       Impact factor: 14.808

7.  Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

Authors:  Min Hu; Pingwei Li; Muyang Li; Wenyu Li; Tingting Yao; Jia-Wei Wu; Wei Gu; Robert E Cohen; Yigong Shi
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

8.  The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.

Authors:  Francesco Morra; Francesco Merolla; Virginia Napolitano; Gennaro Ilardi; Caterina Miro; Simona Paladino; Stefania Staibano; Aniello Cerrato; Angela Celetti
Journal:  Oncotarget       Date:  2017-05-09

9.  Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma.

Authors:  Alexander Beck; Franziska Trippel; Alexandra Wagner; Saskia Joppien; Max Felle; Christian Vokuhl; Thomas Schwarzmayr; Tim M Strom; Dietrich von Schweinitz; Gernot Längst; Roland Kappler
Journal:  Clin Epigenetics       Date:  2018-03-02       Impact factor: 6.551

10.  Expression of HAUSP in gliomas correlates with disease progression and survival of patients.

Authors:  Chuandong Cheng; Chaoshi Niu; Yang Yang; Yang Wang; Manman Lu
Journal:  Oncol Rep       Date:  2013-03-12       Impact factor: 3.906

View more
  13 in total

Review 1.  Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

Authors:  Blanca T Gutierrez-Diaz; Wei Gu; Panagiotis Ntziachristos
Journal:  Trends Immunol       Date:  2020-03-02       Impact factor: 16.687

2.  Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.

Authors:  Xue Li; Lingmei Kong; Qihong Yang; Aizhu Duan; Xiaoman Ju; Bicheng Cai; Lin Chen; Tao An; Yan Li
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

3.  Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.

Authors:  Yalu Zhou; Cuijuan Han; Eric Wang; Adam H Lorch; Valentina Serafin; Byoung-Kyu Cho; Blanca T Gutierrez Diaz; Julien Calvo; Celestia Fang; Alireza Khodadadi-Jamayran; Tommaso Tabaglio; Christian Marier; Anna Kuchmiy; Limin Sun; George Yacu; Szymon K Filip; Qi Jin; Yoh-Hei Takahashi; David R Amici; Emily J Rendleman; Radhika Rawat; Silvia Bresolin; Maddalena Paganin; Cheng Zhang; Hu Li; Irawati Kandela; Yuliya Politanska; Hiam Abdala-Valencia; Marc L Mendillo; Ping Zhu; Bruno Palhais; Pieter Van Vlierberghe; Tom Taghon; Iannis Aifantis; Young Ah Goo; Ernesto Guccione; Adriana Heguy; Aristotelis Tsirigos; Keng Boon Wee; Rama K Mishra; Francoise Pflumio; Benedetta Accordi; Giuseppe Basso; Panagiotis Ntziachristos
Journal:  Cancer Discov       Date:  2020-05-22       Impact factor: 39.397

Review 4.  Coupling Conjugation and Deconjugation Activities to Achieve Cellular Ubiquitin Dynamics.

Authors:  Casey P Nielsen; Jason A MacGurn
Journal:  Trends Biochem Sci       Date:  2020-02-28       Impact factor: 13.807

5.  METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.

Authors:  Yaqin Li; Xianyi Cheng; Yihua Chen; Tao Zhou; Dezhi Li; Wei V Zheng
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 6.  Protein post-translational modifications in the regulation of cancer hallmarks.

Authors:  Haiying Wang; Liqian Yang; Minghui Liu; Jianyuan Luo
Journal:  Cancer Gene Ther       Date:  2022-04-07       Impact factor: 5.854

7.  The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stability in response to toxic metal exposure.

Authors:  John Jw Han; Daniel V Ho; Hyun M Kim; Jun Y Lee; Yerin S Jeon; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2021-04-29       Impact factor: 5.157

8.  The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits.

Authors:  Izaskun Mitxitorena; Domenico Somma; Jennifer P Mitchell; Matti Lepistö; Christian Tyrchan; Emma L Smith; Patrick A Kiely; Helen Walden; Karen Keeshan; Ruaidhrí J Carmody
Journal:  J Biol Chem       Date:  2020-06-25       Impact factor: 5.157

9.  Ubiquitin-specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies.

Authors:  Aleksandra Pawlak; Joanna Bajzert; Katarzyna Bugiel; Beatriz Hernández Suárez; Justyna Kutkowska; Andrzej Rapak; Wojciech Hildebrand; Bożena Obmińska-Mrukowicz; Raimundo Freire; Veronique A J Smits
Journal:  J Vet Intern Med       Date:  2021-03-02       Impact factor: 3.333

Review 10.  Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

Authors:  Si-Min Qi; Gang Cheng; Xiang-Dong Cheng; Zhiyuan Xu; Beihua Xu; Wei-Dong Zhang; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.